J Korean Cancer Assoc.  1997 Jun;29(3):422-428.

A Clinicopathologic Analysis of Medullary Breast Cancer

Affiliations
  • 1Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

PURPOSE: Medullary carcinoma of breast was known to have a better prognosis than other breast cancer, but the histopathological definition of medullary carcinoma has varied with time. This study was performed to clarify the clinicopathologic features of medullary breast cancer.
MATERIALS AND METHODS
Twenty cases of breast cancer originally were diagnosed as medullary carcinoma at the Department of Surgery, Seoul National University Hospital from Jan. 1985 to Jun. 1995. The whole cases were reviewed and reclassified using the strictly defined histologic criteria applied by Ridolfi et al.
RESULTS
When reclassified, 16 tumors fulfilled the criteria of typical medullary cancer. But the rest 4 tumors were found to be nonmedullary cancer. The patients ranged from 29 to 69 years in age with an average of 49. The main symptom was the painless mass. The diameter of the tumor ranged from 1 to 8 cm with a mean size of 2.7 cm. The axillary lymph node was positive in three cases. The estrogen receptor was positive in 10%, and the progesterone receptor was positive in 20% of the cases. There were no local recurrences or distant metastasis during a mean follow-up period of 5.5 years.. All patients survived until the last follow-up.
CONCLUSION
Medullary breast cancer has good prognosis but strict, uniform histopathological diagnostic criteria are needed.

Keyword

Medullary breast cancer

MeSH Terms

Breast Neoplasms*
Breast*
Carcinoma, Medullary
Estrogens
Follow-Up Studies
Humans
Lymph Nodes
Neoplasm Metastasis
Prognosis
Receptors, Progesterone
Recurrence
Seoul
Estrogens
Receptors, Progesterone
Full Text Links
  • JKCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr